Inventiva SA (IVA)
2.67
-0.24
(-8.25%)
USD |
NASDAQ |
Jun 21, 16:00
2.80
+0.13
(+4.87%)
After-Hours: 20:00
Inventiva Total Assets (Quarterly): 76.89M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 76.89M |
| June 30, 2023 | 76.96M |
| June 30, 2023 | 76.96M |
| December 31, 2022 | 124.40M |
| June 30, 2022 | 113.23M |
| June 30, 2022 | 113.23M |
| June 30, 2021 | 139.49M |
| March 31, 2021 | 155.00M |
| June 30, 2020 | 77.29M |
| December 31, 2019 | 63.80M |
| Date | Value |
|---|---|
| June 30, 2019 | 69.41M |
| June 30, 2019 | 69.41M |
| December 31, 2018 | 91.30M |
| June 30, 2018 | 110.76M |
| June 30, 2018 | 110.76M |
| December 31, 2017 | 89.22M |
| June 30, 2017 | 93.18M |
| June 30, 2017 | 93.18M |
| December 31, 2016 | 51.79M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
63.80M
Minimum
Dec 2019
155.00M
Maximum
Mar 2021
96.34M
Average
77.13M
Median
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | 145.90M |
| Cellectis SA | 354.46M |
| Genfit SA | 192.20M |
| Innate Pharma SA | 203.61M |
| Nanobiotix SA | 103.79M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 112.30M |
| Shareholders Equity (Quarterly) | -35.41M |
| Debt to Equity Ratio | -0.9654 |
| Current Ratio | 0.9607 |
| Net Debt Paydown Yield | -2.57% |